Comparison of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on the Genotyping (MAESTRO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01174693
Recruitment Status : Completed
First Posted : August 4, 2010
Last Update Posted : March 17, 2015
Myung In Pharmaceutical Company
Yonsei University
Information provided by (Responsible Party):
KyungYul Lee, Gangnam Severance Hospital